丹参酮ⅡA磺酸钠治疗急性冠状动脉综合征不稳定型心绞痛566例疗效分析

Clinical analysis of therapeutic efficiency of Danshentong on 566 patients with acute coronary syndrome unstable angina pectoris

目的观察丹参酮ⅡA磺酸钠注射液治疗急性冠脉综合征不稳定型心绞痛患者的临床疗效。方法选取566例住院患者(均符合入选标准),分成治疗组和对照组。分别观察两组治疗前后的胸痛的性质、部位、诱因、持续的时间和缓解的因素,发作的频率等情况;观察心电图、血脂、血压、心肌酶等的变化情况;观察药物的不良反应等。结果治疗后临床症状明显改善,治疗组的各项检查指标优于对照组,差异均有统计学意义(P<0.05)。结论丹参酮IIA磺酸钠治疗急性冠脉综合征不稳定型心绞痛疗效显著。

Objective To observe the therapeutic efficiency of DanshentongⅡA on the patients with acute coronary syndrome（unstable angina pectoris）.Methods Totally 566 in-hospital patients with acute coronary syndrome（unstable angina pectoris） were divided into 2 group： therapeutic group and control group.The characteristics of chest pain,frequency of attack,and way of relieve symptom were observed in two groups.The changes of ECG,blood lipid,level of BP were analyed in every patient.Side effects from the use of drugs were assessed.Results The clinical symptoms were improved obviously in all patients,and the all of clinical index in patients of DanshentongⅡA group were superior to the control group.Conclusions DanshentongⅡA injection is an marked effective drug for treating acute coronary syndrome（unstable angina pectoris）.